285 related articles for article (PubMed ID: 28382968)
1. Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease that is partially rescued by riboflavin.
Rizzo F; Ramirez A; Compagnucci C; Salani S; Melzi V; Bordoni A; Fortunato F; Niceforo A; Bresolin N; Comi GP; Bertini E; Nizzardo M; Corti S
Sci Rep; 2017 Apr; 7():46271. PubMed ID: 28382968
[TBL] [Abstract][Full Text] [Related]
2. SLC52A3, A Brown-Vialetto-van Laere syndrome candidate gene is essential for mouse development, but dispensable for motor neuron differentiation.
Intoh A; Suzuki N; Koszka K; Eggan K
Hum Mol Genet; 2016 May; 25(9):1814-23. PubMed ID: 26976849
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of motor dysfunction in a childhood motor neuron disease caused by mutations in the riboflavin transporter.
Menezes MP; Farrar MA; Webster R; Antony J; O'Brien K; Ouvrier R; Kiernan MC; Burns J; Vucic S
Clin Neurophysiol; 2016 Jan; 127(1):911-918. PubMed ID: 26092362
[TBL] [Abstract][Full Text] [Related]
4. Brown-Vialetto-van Laere and Fazio-Londe overlap syndromes: a clinical, biochemical and genetic study.
Ciccolella M; Catteruccia M; Benedetti S; Moroni I; Uziel G; Pantaleoni C; Chiapparini L; Bizzi A; D'Amico A; Fattori F; Salsano ML; Pastore A; Tozzi G; Piemonte F; Bertini E
Neuromuscul Disord; 2012 Dec; 22(12):1075-82. PubMed ID: 22824638
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in riboflavin transporter RFVT and its genetic disease.
Jin C; Yonezawa A
Pharmacol Ther; 2022 May; 233():108023. PubMed ID: 34662687
[TBL] [Abstract][Full Text] [Related]
6. Clinical, pathological and functional characterization of riboflavin-responsive neuropathy.
Manole A; Jaunmuktane Z; Hargreaves I; Ludtmann MHR; Salpietro V; Bello OD; Pope S; Pandraud A; Horga A; Scalco RS; Li A; Ashokkumar B; Lourenço CM; Heales S; Horvath R; Chinnery PF; Toro C; Singleton AB; Jacques TS; Abramov AY; Muntoni F; Hanna MG; Reilly MM; Revesz T; Kullmann DM; Jepson JEC; Houlden H
Brain; 2017 Nov; 140(11):2820-2837. PubMed ID: 29053833
[TBL] [Abstract][Full Text] [Related]
7. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.
Foley AR; Menezes MP; Pandraud A; Gonzalez MA; Al-Odaib A; Abrams AJ; Sugano K; Yonezawa A; Manzur AY; Burns J; Hughes I; McCullagh BG; Jungbluth H; Lim MJ; Lin JP; Megarbane A; Urtizberea JA; Shah AH; Antony J; Webster R; Broomfield A; Ng J; Mathew AA; O'Byrne JJ; Forman E; Scoto M; Prasad M; O'Brien K; Olpin S; Oppenheim M; Hargreaves I; Land JM; Wang MX; Carpenter K; Horvath R; Straub V; Lek M; Gold W; Farrell MO; Brandner S; Phadke R; Matsubara K; McGarvey ML; Scherer SS; Baxter PS; King MD; Clayton P; Rahman S; Reilly MM; Ouvrier RA; Christodoulou J; Züchner S; Muntoni F; Houlden H
Brain; 2014 Jan; 137(Pt 1):44-56. PubMed ID: 24253200
[TBL] [Abstract][Full Text] [Related]
8. Brown-Vialetto-Van Laere syndrome: a riboflavin-unresponsive patient with a novel mutation in the C20orf54 gene.
Koy A; Pillekamp F; Hoehn T; Waterham H; Klee D; Mayatepek E; Assmann B
Pediatr Neurol; 2012 Jun; 46(6):407-9. PubMed ID: 22633641
[TBL] [Abstract][Full Text] [Related]
9. Brown-Vialetto-van Laere syndrome: a riboflavin responsive neuronopathy of infancy with singular features.
Spagnoli C; Pitt MC; Rahman S; de Sousa C
Eur J Paediatr Neurol; 2014 Mar; 18(2):231-4. PubMed ID: 24206674
[TBL] [Abstract][Full Text] [Related]
10. A case report of sudden-onset auditory neuropathy spectrum disorder associated with Brown-Vialetto-Van Laere syndrome (riboflavin transporter deficiency).
Gedik Soyuyuce O; Ayanoglu Aksoy E; Yapici Z
Int J Audiol; 2022 Mar; 61(3):258-264. PubMed ID: 33983862
[TBL] [Abstract][Full Text] [Related]
11. Madras motor neuron disease (MMND) is distinct from the riboflavin transporter genetic defects that cause Brown-Vialetto-Van Laere syndrome.
Nalini A; Pandraud A; Mok K; Houlden H
J Neurol Sci; 2013 Nov; 334(1-2):119-22. PubMed ID: 24139842
[TBL] [Abstract][Full Text] [Related]
12. The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives.
Bosch AM; Stroek K; Abeling NG; Waterham HR; Ijlst L; Wanders RJ
Orphanet J Rare Dis; 2012 Oct; 7():83. PubMed ID: 23107375
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience.
Jaeger B; Bosch AM
J Inherit Metab Dis; 2016 Jul; 39(4):559-64. PubMed ID: 26973221
[TBL] [Abstract][Full Text] [Related]
14. Riboflavin transporter 3 involvement in infantile Brown-Vialetto-Van Laere disease: two novel mutations.
Ciccolella M; Corti S; Catteruccia M; Petrini S; Tozzi G; Rizza T; Carrozzo R; Nizzardo M; Bordoni A; Ronchi D; D'Amico A; Rizzo C; Comi GP; Bertini E
J Med Genet; 2013 Feb; 50(2):104-7. PubMed ID: 23243084
[TBL] [Abstract][Full Text] [Related]
15. Auditory neuropathy in Brown-Vialetto-Van Laere syndrome due to riboflavin transporter RFVT2 deficiency.
Menezes MP; O'Brien K; Hill M; Webster R; Antony J; Ouvrier R; Birman C; Gardner-Berry K
Dev Med Child Neurol; 2016 Aug; 58(8):848-54. PubMed ID: 26918385
[TBL] [Abstract][Full Text] [Related]
16. A Case Report of Riboflavin Treatment and Cochlear Implants in a 4-Year-Old Girl with Progressive Hearing Loss and Delayed Speech Development: Brown-Vialetto-Van Laere Syndrome.
Piecuch AK; Skarżyński PH; Skarżyński H
Am J Case Rep; 2023 Oct; 24():e940439. PubMed ID: 37786244
[TBL] [Abstract][Full Text] [Related]
17. Genetic, Radiologic, and Clinical Variability in Brown-Vialetto-van Laere Syndrome.
Woodcock IR; Menezes MP; Coleman L; Yaplito-Lee J; Peters H; White SM; Stapleton R; Phelan DG; Chong B; Lunke S; Stark Z; Pitt J; Ryan MM; Robertson C; Yiu EM
Semin Pediatr Neurol; 2018 Jul; 26():2-9. PubMed ID: 29961509
[TBL] [Abstract][Full Text] [Related]
18. Brown-Vialetto-Van Laere and Fazio Londe syndromes: defects of riboflavin transport with biochemical similarities to multiple acyl-CoA dehydrogenation defects (MADD).
Bennett MJ
J Inherit Metab Dis; 2012 Nov; 35(6):941-2. PubMed ID: 22976761
[No Abstract] [Full Text] [Related]
19. A Chinese pedigree with Brown-Vialetto-Van Laere syndrome due to two novel mutations of SLC52A2 gene: clinical course and response to riboflavin.
Shi K; Shi Z; Yan H; Wang X; Yang Y; Xiong H; Gu Q; Wu Y; Jiang Y; Wang J
BMC Med Genet; 2019 May; 20(1):76. PubMed ID: 31064337
[TBL] [Abstract][Full Text] [Related]
20. Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown-Vialetto-Van Laere syndrome.
Haack TB; Makowski C; Yao Y; Graf E; Hempel M; Wieland T; Tauer U; Ahting U; Mayr JA; Freisinger P; Yoshimatsu H; Inui K; Strom TM; Meitinger T; Yonezawa A; Prokisch H
J Inherit Metab Dis; 2012 Nov; 35(6):943-8. PubMed ID: 22864630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
